Tata India Pharma & Healthcare Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Invest NowTata India Pharma & Healthcare Fund-Regular Plan-Growth
Invest NowChart Comparison
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1383 Cr | ₹1208 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹100 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 28 Sep 2023 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | Nifty Pharma TRI |
Turn Over | % | 26.49% |
Expense Ratio | 2.17 | 2.14 |
Manager | Dhruv Muchhal | Meeta Shetty |
ISIN Code | INF179KC1HL7 | INF277K016A9 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 3.72% | 4.66% |
6 Month | 24.41% | 16.53% |
1 Year | 51.26% | 41.34% |
3 Year | - | 22.4% |
5 Year | - | 27.33% |
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | - | - |
1 Year | 45.69% | 31.82% |
3 Year | - | 32.32% |
5 Year | - | 25.8% |
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 62.28% | 6.67% |
3 Year | - | 17.46% |
5 Year | - | 14.22% |
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | - | 14.23% |
Sharp | - | 0.74% |
Beta | - | 0.9% |
Alpha | - | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts GuidanceScheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Dhruv Muchhal | Meeta Shetty |
Total AUM | ₹520687 Cr | ₹17847 Cr |
Fund Manage | 40 | 5 |
HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.98 | 5.39 |
Small Cap | 33.12 | 23.46 |
Large Cap | 32.5 | 40.33 |
Mid Cap | 32.4 | 30.82 |
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.98 | 5.39 |
Pharmaceuticals & Biotechnology | 74.71 | 76.28 |
Healthcare Services | 22.28 | 14.31 |
Retailing | 1.03 | 0.66 |
Fertilizers & Agrochemicals | - | 0.83 |
Chemicals & Petrochemicals | - | 0.39 |
Insurance | - | 2.14 |
Top Comparisons
Aditya Birla Sun Life Global Emerging Opportunities Fund - Regular Plan - Growth Option
3Y Returns4.93%
HSBC Asia Pacific (Ex Japan) Dividend Yield Fund - Growth
3Y Returns3.54%
Sundaram Short Duration Fund Regular Growth
3Y Returns6.03%
UTI Short Duration Fund - Discontinued Regular Option -Growth Sub Option
3Y Returns5.76%
ICICI Prudential Infrastructure Fund - Growth
3Y Returns33.97%
Quant Infrastructure Fund - Growth Option
3Y Returns23.58%
BANDHAN Sterling Value Fund - Regular Plan - Growth
3Y Returns18.82%
Axis Value Fund - Regular Plan - Growth
3Y Returns21.58%